Evommune, Inc. (EVMN) Total liabilities 2024–2025
Evommune, Inc. (EVMN) total liabilities at each fiscal year-end, per SEC filings.
$19.4MFY2025 · since FY2024: $28.5M → $19.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $19.4M | -32.0% |
| FY2024 | $28.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More EVMN financial trends
EVMN RevenueEVMN Net incomeEVMN Net marginEVMN Gross profitEVMN Gross marginEVMN Operating incomeEVMN Operating marginEVMN Operating cash flowEVMN Free cash flowEVMN Capital expendituresEVMN Return on equityEVMN Stock buybacksEVMN Dividends paidEVMN Total assetsEVMN Shareholders’ equityEVMN overview →